Advertisement

Fibromyalgia, Arthritic, and Myofascial Pain

  • Nalini Vadivelu
  • Richard D. Urman
Chapter

Abstract

Fibromyalgia (FMS) is an idiopathic painful syndrome of a chronic nature and of unclear etiology. It is more prevalent in females with a ratio of 9:1 females to males. About 5 million people in the United States are thought to suffer from fibromyalgia. It is estimated to be present in 2–7% of the population in most countries and is a debilitating illness with resultant loss of work days and school days, disability, and functional impairment.

Keywords

Rheumatoid Arthritis Irritable Bowel Syndrome Chronic Fatigue Syndrome Trigger Point Cold Spray 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005;23(Suppl. 39):S154–S162.Google Scholar
  2. Chakrabarty S, Zoorob R. Fibromyalgia. Am Fam Physician 2007 Jul;76(2):247–54.PubMedGoogle Scholar
  3. Gürsoy S, Erdal E, Herken H, Madenci E, Alaşehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int. 2003 May;23(3):104–7.PubMedGoogle Scholar
  4. Hudson J, Pope HJ. The relationship between fibromyalgia and major depressive disorder. Rheum Dis Clin North Am. 1996 May;22(2):285–303.PubMedCrossRefGoogle Scholar
  5. Lawrence R, Felson D, Helmick C, Arnold L, Choi H, Deyo R, Gabriel S, Hirsch R, Hochberg M, Hunder G, Jordan J, Katz J, Kremers H, Wolfe F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008 Jan;58(1):26–35.PubMedCrossRefGoogle Scholar
  6. McBeth J, Silman A, Gupta A, Chiu Y, Ray D, Morriss R, Dickens C, King Y, Macfarlane G. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum. 2007 Jan;56(1):360–71.PubMedCrossRefGoogle Scholar
  7. Raphael K, Janal M, Nayak S, Schwartz J, Gallagher R. Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain 2006 Sep;124(1–2):117–25.PubMedCrossRefGoogle Scholar
  8. Russell I, Raphael K. Fibromyalgia syndrome: presentation, diagnosis, differential diagnosis, and vulnerability. CNS Spectr. 2008 Mar;13(3 suppl 5):6–11.PubMedGoogle Scholar
  9. Tofferi J, Jackson J, O’Malley P. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 2004 Feb;51(1):9–13.PubMedCrossRefGoogle Scholar
  10. Wolfe F, Smythe H, Yunus M, Bennett R, Bombardier C, Goldenberg D, Tugwell P, Campbell S, Abeles M, Clark P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. >Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160–72.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Nalini Vadivelu
    • 1
  • Richard D. Urman
    • 2
  1. 1.Department of AnesthesiologyYale University School of MedicineNew HavenUSA
  2. 2.Department of AnesthesiaHarvard Medical School/Brigham and Women’s HospitalBostonUSA

Personalised recommendations